Thus, we provide a potential link between HFD-associated SGs and the pathogenesis of obesity and related diseases, indicating that Pdcd4 may be a novel therapeutic target for resolving SG-associated stress responses. This evidence concerns the gene PDCD4 and obesity due to melanocortin 4 receptor deficiency.